Maravai Lifesciences (MRVI) traded up 3.54 % during a 24 hours period ending at 08:01 PM Central Europe on Monday 26th. One Maravai Lifesciences stock can currently be bought for about USD 7.47 on popular exchanges. Current supply of Maravai Lifesciences stocks is 149 mn. Maravai Lifesciences has a current market capitalization of USD 2.7 bn and approximately USD 10.6 mn worth of Maravai Lifesciences was traded on exchanges in the last 24 hours. Since last month end, Maravai Lifesciences has traded -4.31 % down. Simple moving average of last 200 days is at USD 5.13. The highest price of past 52 weeks was recorded at USD 9.42 on 08/26/2026. 52 weeks low was at USD 2.54 on 11/07/2025.
Here is how related stocks have performed in the past 24 hours:
Atkore (ATKR) traded up 0.04 % and now trades at USD 94.96. Current market capitalisation for Atkore is USD 3.2 bn.
Teradata (TDC) traded up 1.96 % and now trades at USD 34.89. Teradata has a market capitalisation of USD 3.2 bn. Current price/earnings ratio for Teradata is 7.33.
Kyndryl (KD) traded down -2.89 % and now trades at USD 14.63. Kyndryl has a market capitalisation of USD 3.2 bn. Current price/earnings ratio for Kyndryl is 38.46.
Alliancebernstein (AB) traded down -0.57 % and now trades at USD 35.21. Alliancebernstein has a market capitalisation of USD 3.3 bn. Current price/earnings ratio for Alliancebernstein is 10.3.
Nmi (NMIH) traded up 2.55 % and now trades at USD 42.9. Nmi has a market capitalisation of USD 3.2 bn. Current price/earnings ratio for Nmi is 8.36.
About Maravai Lifesciences
Maravai LifeSciences Holdings, Inc. is a health care sector company that serves customers worldwide by operating as a holding company. Through its subsidiaries, the company focuses on providing critical products necessary for the development of drug therapies, diagnostics, novel vaccines, and supporting research on human diseases.